O uso de psicotrópicos com efeitos anorexígenos: uma revisão de literatura.

Abstract

Psychotropic drugs are substances with action on the central nervous system that produce changes in behavior, mood and cognition, which can lead to dependence, being classified according to their action on the patient, as depressants, when they will reduce mental activity, increasing the amount of neurotransmitters inhibitors or by reducing stimulatory neurotransmitters. The general objective of the study was to analyze the role of psychotropic drugs that have anorexigenic effects, addressing the main characteristics and consequences of their use, aiming at the importance of the pharmacist in patient guidance. The method used was an integrative literature review, for the analysis of concepts, review of theories or evidence and synthesis of knowledge on the subject, allowing to identify gaps that need to be filled with the performance of new studies. Anorectic psychotropics, which were divided into classes, such as catecholaminergics: femproporex, amfepramone, mazindol. Serotonergics: fluoxetine and sertraline. Sibutramine that have catecholaminergic and serotonergic characteristics. Thermogenics that have ephedrine as the main drug. The selective ones of the endocannabinoid system, example of rimonabant. Other anorectic psychotropics were topiramate and bupropion, all of which have characteristics that may seem beneficial at first, however, abusive and indiscriminate use has serious side effects such as dependence, promoting undesirable effects such as delusions, tachycardia, mydriasis, among others. effects that can even lead to the death of the individual. The lack of information along with easy access to medicines has influenced the indiscriminate use of these drugs, so pharmaceutical care is essential for their rational use to take place. It is of paramount importance that the pharmacist guide the population regarding the correct way of use, adverse reactions, drug interactions, drug benefits and the need for demedicalization.